Chemical site-selective protein modification: Development of a traceless vascular targeting ADC for cancer therapy (2012)
Attributed to:
Engineering stable calibration standards for biomedical research
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 243
Parent Publication: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
ISSN: 0065-7727